228 related articles for article (PubMed ID: 26651553)
21. [Do thiazolidinediones harm skeletal integrity?].
Takeuchi Y
Clin Calcium; 2008 May; 18(5):650-5. PubMed ID: 18445884
[TBL] [Abstract][Full Text] [Related]
22. Impact of diabetes and its treatments on skeletal diseases.
Yan W; Li X
Front Med; 2013 Mar; 7(1):81-90. PubMed ID: 23377889
[TBL] [Abstract][Full Text] [Related]
23. Association of proliferative diabetic retinopathy with insulin use and microalbuminuria.
Chu SH; Li AH
Arch Ophthalmol; 2010 Jan; 128(1):146; author reply 146-7. PubMed ID: 20065240
[No Abstract] [Full Text] [Related]
24. Thiazolidinediones and fracture risk in patients with Type 2 diabetes.
Betteridge DJ
Diabet Med; 2011 Jul; 28(7):759-71. PubMed ID: 21672000
[TBL] [Abstract][Full Text] [Related]
25. Thiazolidinedione treatment decreases bone mineral density in type 2 diabetic men.
Yaturu S; Bryant B; Jain SK
Diabetes Care; 2007 Jun; 30(6):1574-6. PubMed ID: 17363747
[No Abstract] [Full Text] [Related]
26. Insights into bone fragility in diabetes: the crucial role of bone quality on skeletal strength.
Yamamoto M
Endocr J; 2015; 62(4):299-308. PubMed ID: 25797364
[TBL] [Abstract][Full Text] [Related]
27. Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus.
Gerdhem P; Isaksson A; Akesson K; Obrant KJ
Osteoporos Int; 2005 Dec; 16(12):1506-12. PubMed ID: 15824889
[TBL] [Abstract][Full Text] [Related]
28. Our Evolving Understanding of the Relationship Between Diabetes and Bone.
Kotwal A; Drake MT
Am J Med Sci; 2017 Oct; 354(4):333-334. PubMed ID: 29078835
[No Abstract] [Full Text] [Related]
29. Rosiglitazone decreases bone mineral density and increases bone turnover in postmenopausal women with type 2 diabetes mellitus.
Bilezikian JP; Josse RG; Eastell R; Lewiecki EM; Miller CG; Wooddell M; Northcutt AR; Kravitz BG; Paul G; Cobitz AR; Nino AJ; Fitzpatrick LA
J Clin Endocrinol Metab; 2013 Apr; 98(4):1519-28. PubMed ID: 23450056
[TBL] [Abstract][Full Text] [Related]
30. Diabetes mellitus, bone mineral density, and fracture risk.
Strotmeyer ES; Cauley JA
Curr Opin Endocrinol Diabetes Obes; 2007 Dec; 14(6):429-35. PubMed ID: 17982347
[TBL] [Abstract][Full Text] [Related]
31. Skeletal Metabolism, Fracture Risk, and Fracture Outcomes in Type 1 and Type 2 Diabetes.
Sellmeyer DE; Civitelli R; Hofbauer LC; Khosla S; Lecka-Czernik B; Schwartz AV
Diabetes; 2016 Jul; 65(7):1757-66. PubMed ID: 27329951
[TBL] [Abstract][Full Text] [Related]
32. [Diabetes and osteoporosis].
Valkusz Z
Orv Hetil; 2011 Jul; 152(29):1161-6. PubMed ID: 21712181
[TBL] [Abstract][Full Text] [Related]
33. Importance of Metabolic Memory in the Development of Vascular Complications in Diabetic Patients.
Luna P; Guarner V; Farías JM; Hernández-Pacheco G; Martínez M
J Cardiothorac Vasc Anesth; 2016 Oct; 30(5):1369-78. PubMed ID: 27256447
[No Abstract] [Full Text] [Related]
34. [Thiazolidinediones and skeletal health].
Meier C; Bodmer M; Meier CR; Kraenzlin ME
Rev Med Suisse; 2009 Jun; 5(207):1309-10, 1312-3. PubMed ID: 19626930
[TBL] [Abstract][Full Text] [Related]
35. Bone loss and fracture risk associated with thiazolidinedione therapy.
Riche DM; King ST
Pharmacotherapy; 2010 Jul; 30(7):716-27. PubMed ID: 20575635
[TBL] [Abstract][Full Text] [Related]
36. Diabetes and fracture healing: the skeletal effects of diabetic drugs.
Simpson CM; Calori GM; Giannoudis PV
Expert Opin Drug Saf; 2012 Mar; 11(2):215-20. PubMed ID: 22145960
[TBL] [Abstract][Full Text] [Related]
37. [Daily practice using the guidelines for prevention and treatment of osteoporosis. Anti-diabetic agents and fracture risk].
Okazaki R
Clin Calcium; 2008 Aug; 18(8):1154-61. PubMed ID: 18677054
[TBL] [Abstract][Full Text] [Related]
38. Effects of rosiglitazone on bone mineral density and remodelling parameters in Postmenopausal diabetic women: a 2-year follow-up study.
Berberoglu Z; Yazici AC; Demirag NG
Clin Endocrinol (Oxf); 2010 Sep; 73(3):305-12. PubMed ID: 20148906
[TBL] [Abstract][Full Text] [Related]
39. Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes.
Aubert RE; Herrera V; Chen W; Haffner SM; Pendergrass M
Diabetes Obes Metab; 2010 Aug; 12(8):716-21. PubMed ID: 20590749
[TBL] [Abstract][Full Text] [Related]
40. Impact of Type 2 Diabetes Mellitus and Antidiabetic Medications on Bone Metabolism.
Lee HS; Hwang JS
Curr Diab Rep; 2020 Nov; 20(12):78. PubMed ID: 33247351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
